Publications
146
Citations
1,908
Est. group size
~17
Recurring co-author estimate
Active years
28
Publishing since 1999
Typically publishes in teams of ~4 · 30% small-team papers (≤3 authors) · across 7 venues
- Histone mark remodeling in cancer: an enhancer-centered perspective
Genes & Genomics · 2026
- <i>In Silico</i> Prediction of EZHIP Post-Translational Modification Sites and Small-Molecule High-Throughput Screening for Quantitative EZHIP Modulation
Brain Tumor Research and Treatment · 2026
- Integrated transcriptomic analysis reveals KRAS-associated gene activation and epigenetic regulation in mutant IDH1 glioma
Genes & Genomics · 2026
- P4.11E.28 Pharmacological Comparison of Dostarlimab and Pembrolizumab in Metastatic Non-Small Cell Lung Cancer in PERLA
Journal of Thoracic Oncology · 2024
- Epigenetic and Metabolic Changes in Diffuse Intrinsic Pontine Glioma
Brain Tumor Research and Treatment · 2023
- Odorant receptors in cancer
BMB Reports · 2022
- Blood based molecular profiling: the future of pancreatic adenocarcinoma detection
HPB · 2021
- Molecular Profiling Practices in Pancreatic Adenocarcinoma: Academic versus Community Providers
HPB · 2021
- PO-0734 Patterns of Care in the Management of WHO Grade II and III Spinal Ependymomas
Radiotherapy and Oncology · 2019
- Niemann-Pick Type C disease: Protective mechanisms from neurodegeneration and targets for therapeutic intervention
Deep Blue (University of Michigan) · 2016
- Neuro-Oncology×10
- Science Translational Medicine×3
- Cancer Research×3
- Cancer Cell×2
- Cancer Discovery×2
- Dana Messinger
Medicine · University of Michigan
- Carl Koschmann
Medicine · University of Michigan
- Akash Deogharkar
Medicine · University of Michigan
- Andrea Franson
Medicine · University of Michigan
- Heidi Baum
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile